Adjusted versus fixed doses of the low-molecular-weight heparin fragmin in the treatment of deep vein thrombosis. Fragmin-Study Group.

Martine Alhenc‐Gelas, C Jestin-Le Guernic, J.F. Vitoux, +3

PubMed

Low-molecular-weight Heparin FragminDeep Vein ThrombosisPharmacotherapyStandard Heparin TherapyThrombosis +16

Adjusted Versus Fixed Doses of the Low-Molecular-Weight Heparin Fragmin in the Treatment of Deep Vein Thrombosis

Martine Alhenc‐Gelas, C. Jestin-Le Guernic, J.F. Vitoux, +3

Thrombosis and Haemostasis

Low-molecular-weight Heparin FragminDeep Vein ThrombosisPharmacotherapyStandard Heparin TherapyThrombosis +16

Heparin-Associated Thrombocytopenia Treatment with Low Molecular Weight Heparin

J.F. Vitoux, Jean-F Mathieu, M Roncato, +2

Thrombosis and Haemostasis

ThrombopoiesisThrombosisVenous ThrombosisHepatologyBlood Platelet +12

Acute peripheral arterial and graft occlusion: treatment with selective infusion of urokinase and lysyl plasminogen.

Jean-Marc Pernès, J.F. Vitoux, P Brenoit, +7

Radiology

Continuous UrokinaseVascular TraumaSurgeryThrombosisVenous Thrombosis +18

Local thrombolysis in peripheral arteries and bypass grafts

Jean-Marc Pernès, Marco Augusto, J.F. Vitoux, +6

Journal of Vascular Surgery

ThrombosisVenous ThrombosisCardiovascular DiseasePeripheral InterventionVascular Surgery +4

Circulating Activities During Constant Infusion of Heparin or a Low Molecular Weight Derivative (Enoxaparine): Failure to Demonstrate any Circadian Variations

Pierre Toulon, J.F. Vitoux, C Leroy, +5

Thrombosis and Haemostasis

Constant Heparin InfusionHomeostatic MechanismImmunologyCircadian VariationsThrombosis +22

Heparin cofactor II in patients with deep venous thrombosis under heparin and oral anticoagulant therapy

Pierre Toulon, J.F. Vitoux, L Capron, +3

Thrombosis Research

ThrombosisDeep Venous ThrombosisVenous ThrombosisCardiovascular DiseaseOral Anticoagulant Therapy +9

High total and free protein S in patients with acute deep vein thrombosis

Pierre Toulon, Sophie Gandrille, J.F. Vitoux, +3

Thrombosis Research

ThrombopoiesisThrombosisVenous DiseaseVenous ThrombosisProteomics +9

Thrombolytic Treatment in Obliterative Arterial Disease

Jean‐Noël Fiessinger, Martine Aiach, J.F. Vitoux, +3

Pathophysiology of Haemostasis and Thrombosis

ThrombosisVenous ThrombosisCardiovascular DiseaseMedicineHematology +7

Heparin cofactor II

Pierre Toulon, J.F. Vitoux, J N Fiessinger, +2

Blood Coagulation & Fibrinolysis

ImmunologyMolecular BiologyPathologyHcii DeficiencyThrombosis +18